Neffy for severe allergic reactions and Dupixent for chronic obstructive pulmonary disease (COPD), which all gained FDA approval this year. These medications are "slated to make a big clinical ...

The FDA grants orphan status to medicines and biologics for rare diseases that meet certain criteria, opening the way for incentives such as accelerated approval and tax breaks to support their ...

Four years after getting the first drug approved by the FDA to treat rare disease hereditary ATTR amyloidosis, Alnylam has got the go-ahead for a second – Amvuttra – which has a simpler ...

Prior to Alyftrek’s approval, Vertex had previously brought four cystic fibrosis medicines to market, building a business that generated nearly $10 billion in 2023. Sales are expected to surpass that ...

When applied to your lash line on a daily basis, Latisse promotes the growth of lashes by extending the growth phase of the ...

(Nasdaq: CPIX), a specialty pharmaceutical company focused on delivering high-quality products to improve patient care, announced today the FDA has approved a supplemental New Drug Application ...

Sleep apnea causes people to stop and start breathing repeatedly Zepbound is first drug approved by FDA to help treat it Two studies found that those who used it saw reduction in apnea events ...

The U.S. Food and Drug Administration (FDA) recently granted accelerated approval of a treatment for adults with metastatic biliary tract cancer—a condition with less than a 5 percent five-year ...

On Friday, the FDA approved Checkpoint Therapeutics, Inc.’s (NASDAQ:CKPT) Unloxcyt (cosibelimab-ipdl) for metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced cSCC who are not ...

If you struggle with thinning hair, here's what's causing it. Try one of these thinning hair treatments, including Rogaine, ...

The Food and Drug Administration (FDA) gave the green light to the the first-ever medication for obstructive sleep apnea (OSA). The newly approved drug, Zepbound (tirzepatide), targets adults with ...

The Food and Drug Administration announced late Friday that it has approved Zepbound to treat obstructive sleep apnea for those who are moderately or severely obese. The drug is to be used in ...